<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="research-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Cell Dev. Biol.</journal-id>
<journal-title>Frontiers in Cell and Developmental Biology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Cell Dev. Biol.</abbrev-journal-title>
<issn pub-type="epub">2296-634X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">1110423</article-id>
<article-id pub-id-type="doi">10.3389/fcell.2023.1110423</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Cell and Developmental Biology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Proteomic analysis defines the interactome of telomerase in the protozoan parasite, <italic>Trypanosoma brucei</italic>
</article-title>
<alt-title alt-title-type="left-running-head">Davis et al.</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fcell.2023.1110423">10.3389/fcell.2023.1110423</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Davis</surname>
<given-names>Justin A.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2118488/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Reyes</surname>
<given-names>Andres V.</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1681192/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Nitika</surname>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/623536/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Saha</surname>
<given-names>Arpita</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="fn" rid="fn1">
<sup>&#x2020;</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wolfgeher</surname>
<given-names>Donald J.</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Xu</surname>
<given-names>Shou-Ling</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1250483/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Truman</surname>
<given-names>Andrew W.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/278355/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Li</surname>
<given-names>Bibo</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/34287/overview"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Chakrabarti</surname>
<given-names>Kausik</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1272934/overview"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Department of Biological Sciences</institution>, <institution>University of North Carolina</institution>, <addr-line>Charlotte</addr-line>, <addr-line>NC</addr-line>, <country>United States</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Department of Plant Biology and Carnegie Mass Spectrometry Facility</institution>, <institution>Carnegie Institution for Science</institution>, <addr-line>Stanford</addr-line>, <addr-line>CA</addr-line>, <country>United States</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Center for Gene Regulation in Health and Disease</institution>, <institution>Department of Biological, Geological, and Environmental Sciences</institution>, <institution>College of Arts and Sciences</institution>, <institution>Cleveland State University</institution>, <addr-line>Cleveland</addr-line>, <addr-line>OH</addr-line>, <country>United States</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>Department of Molecular Genetics and Cell Biology</institution>, <institution>The University of Chicago</institution>, <addr-line>Chicago</addr-line>, <addr-line>IL</addr-line>, <country>United States</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1019234/overview">Ziyin Li</ext-link>, University of Texas Health Science Center at Houston, United States</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/862360/overview">Galadriel Hovel-Miner</ext-link>, George Washington University, United States</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/2160030/overview">Mark Woodford</ext-link>, Upstate Medical University, United States</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Kausik Chakrabarti, <email>k.chakrabarti@uncc.edu</email>
</corresp>
<fn fn-type="present-address" id="fn1">
<label>
<sup>&#x2020;</sup>
</label>
<p>Present address: Arpita Saha, Telomeres and Telomerase Group, Molecular Oncology Program, Spanish National Cancer Centre (CNIO), Madrid, Spain</p>
</fn>
<fn fn-type="other">
<p>This article was submitted to Cell Growth and Division, a section of the journal Frontiers in Cell and Developmental Biology</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>16</day>
<month>03</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="collection">
<year>2023</year>
</pub-date>
<volume>11</volume>
<elocation-id>1110423</elocation-id>
<history>
<date date-type="received">
<day>28</day>
<month>11</month>
<year>2022</year>
</date>
<date date-type="accepted">
<day>03</day>
<month>03</month>
<year>2023</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2023 Davis, Reyes, Nitika, Saha, Wolfgeher, Xu, Truman, Li and Chakrabarti.</copyright-statement>
<copyright-year>2023</copyright-year>
<copyright-holder>Davis, Reyes, Nitika, Saha, Wolfgeher, Xu, Truman, Li and Chakrabarti</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>Telomerase is a ribonucleoprotein enzyme responsible for maintaining the telomeric end of the chromosome. The telomerase enzyme requires two main components to function: the telomerase reverse transcriptase (TERT) and the telomerase RNA (TR), which provides the template for telomeric DNA synthesis. TR is a long non-coding RNA, which forms the basis of a large structural scaffold upon which many accessory proteins can bind and form the complete telomerase holoenzyme. These accessory protein interactions are required for telomerase activity and regulation inside cells. The interacting partners of TERT have been well studied in yeast, human, and <italic>Tetrahymena</italic> models, but not in parasitic protozoa, including clinically relevant human parasites. Here, using the protozoan parasite, <italic>Trypanosoma brucei</italic> (<italic>T. brucei</italic>) as a model, we have identified the interactome of <italic>T. brucei</italic> TERT (<italic>Tb</italic>TERT) using a mass spectrometry-based approach. We identified previously known and unknown interacting factors of <italic>Tb</italic>TERT, highlighting unique features of <italic>T. brucei</italic> telomerase biology. These unique interactions with <italic>Tb</italic>TERT, suggest mechanistic differences in telomere maintenance between <italic>T. brucei</italic> and other eukaryotes.</p>
</abstract>
<kwd-group>
<kwd>
<italic>Trypanosoma brucei</italic>
</kwd>
<kwd>cell proliferation</kwd>
<kwd>telomerase</kwd>
<kwd>telomere</kwd>
<kwd>cell growth</kwd>
<kwd>parasite</kwd>
<kwd>interactome</kwd>
<kwd>ribonucleoprotein (RNP)</kwd>
</kwd-group>
<contract-num rid="cn001">1R15AI166764-01A1</contract-num>
<contract-sponsor id="cn001">National Institutes of Health<named-content content-type="fundref-id">10.13039/100000002</named-content>
</contract-sponsor>
</article-meta>
</front>
<body>
<sec id="s1">
<title>1 Introduction</title>
<p>Telomeres are the nucleoprotein structures found at the ends of eukaryotic chromosomes. Conventional DNA polymerases are unable to fully replicate the ends of linear DNA molecules, which leads to progressive telomere shortening after every cell division (<xref ref-type="bibr" rid="B57">Shay and Wright, 2019</xref>). This problem is solved by the ribonucleoprotein enzyme, telomerase. Proper maintenance of the telomeric end is critical for maintaining genome integrity in eukaryotes. The telomerase enzyme has two essential components: the telomerase RNA (TR), which provides the template required for telomeric DNA synthesis (<xref ref-type="bibr" rid="B23">Greider and Blackburn, 1989</xref>); and the catalytic protein telomerase reverse transcriptase (TERT) that catalyzes the <italic>de novo</italic> synthesis of the telomere G-rich strand. The action of telomerase counteracts progressive telomere shortening after every cell division.</p>
<p>TERT and TR are the minimum components required for the telomerase activity <italic>in vitro</italic> (<xref ref-type="bibr" rid="B8">Chen et al., 2000</xref>; <xref ref-type="bibr" rid="B10">Collins, 2006</xref>). TR can form a large structural scaffold upon which many accessory proteins can bind to and form the complete telomerase holoenzyme <italic>in vivo</italic>. These accessory proteins are required for <italic>in vivo</italic> telomerase activity and regulation (<xref ref-type="bibr" rid="B67">Wang et al., 2019</xref>). Interacting partners of the TERT protein have been extensively characterized in yeast, human, and <italic>Tetrahymena</italic> systems, but they have not been extensively studied in parasitic protozoa including clinically relevant human parasites, such as <italic>Trypanosoma brucei</italic> (<italic>T. brucei</italic>). <italic>T. brucei</italic> is the parasite that causes African sleeping sickness in humans. During its life cycle, <italic>T. brucei</italic> will shuttle between an insect vector and a mammalian host. During this time, the parasite will differentiate into distinct developmental stages: Bloodstream form (BF) parasites proliferate in the mammalian host, and Procyclic form (PF) parasites proliferate in the midgut of the insect vector. Unlike human somatic cells, which tightly regulate telomerase activity, <italic>T. brucei</italic> telomerase is constantly active, enabling continued cell division in their hosts, leading to a chronic infection. BF <italic>T. brucei</italic> also has the advantage of evading its host immune response through antigenic variation. During this process, <italic>T. brucei</italic> regularly switches to express different <italic>Variant Surface Glycoproteins</italic> (VSGs), its major surface antigen. <italic>T. brucei</italic> has a very large <italic>VSG</italic> gene pool, but only one <italic>VSG</italic> gene is expressed at any given time. VSGs are expressed exclusively from <italic>VSG</italic> expression sites (ESs), which are large polycistronic transcription units located at subtelomeric loci of the parasite&#x2019;s genome within 2&#xa0;kb of telomeres (<xref ref-type="bibr" rid="B12">De Lange and Borst, 1982</xref>; <xref ref-type="bibr" rid="B27">Hertz-Fowler et al., 2008</xref>). Therefore, telomerase activity is critical to maintain the integrity of these <italic>VSG</italic> genes. In cells where the TERT protein has been deleted (<italic>Tb</italic>TERT<sup>&#x2212;/&#x2212;</sup>), extremely short telomeres adjacent to the active ES leads to an increase in VSG switching frequency (<xref ref-type="bibr" rid="B15">Dreesen and Cross, 2006</xref>; <xref ref-type="bibr" rid="B30">Hovel-Miner et al., 2012</xref>). Telomeric binding proteins have also been shown to affect <italic>VSG</italic> silencing and switching (<xref ref-type="bibr" rid="B70">Yang et al., 2009</xref>; <xref ref-type="bibr" rid="B5">Benmerzouga et al., 2013</xref>; <xref ref-type="bibr" rid="B33">Jehi et al., 2014</xref>; <xref ref-type="bibr" rid="B32">Jehi et al., 2016</xref>; <xref ref-type="bibr" rid="B44">Nanavaty et al., 2017</xref>; <xref ref-type="bibr" rid="B1">Afrin et al., 2020</xref>; <xref ref-type="bibr" rid="B49">Rabbani et al., 2022</xref>). Telomerase mediated telomere maintenance in <italic>T. brucei</italic> is required for the maintenance of subtelomeric <italic>VSG</italic> genes. Because of this, studies of telomerase function and regulation in <italic>T. brucei</italic> could give novel insights into the pathogenicity of this parasite.</p>
<p>The RNA component of <italic>T. brucei</italic> telomerase (<italic>Tb</italic>TR) has a unique structure and sequence composition compared to higher eukaryotes (<xref ref-type="bibr" rid="B52">Sandhu et al., 2013</xref>; <xref ref-type="bibr" rid="B48">Podlevsky et al., 2016</xref>; <xref ref-type="bibr" rid="B14">Dey et al., 2021</xref>). Our recent study on <italic>Tb</italic>TR suggests mechanistic differences in telomere maintenance between <italic>T. brucei</italic> and higher eukaryotes (<xref ref-type="bibr" rid="B14">Dey et al., 2021</xref>; <xref ref-type="bibr" rid="B49">Rabbani et al., 2022</xref>, underscoring the importance of investigating the functional interactome of <italic>T. brucei</italic> telomerase. Previous proteomic studies on ciliated single-cell protozoan <italic>Tetrahymena</italic> identified several RNA binding proteins, including p65 that copurifies with TR and TERT and promotes proper folding of TR for telomerase holoenzyme assembly and activity (<xref ref-type="bibr" rid="B69">Witkin and Collins, 2004</xref>; <xref ref-type="bibr" rid="B6">Berman et al., 2010</xref>; <xref ref-type="bibr" rid="B58">Singh et al., 2012</xref>; <xref ref-type="bibr" rid="B63">Upton et al., 2017</xref>; <xref ref-type="bibr" rid="B26">He et al., 2021</xref>). Although homologs of p65 have not been found outside ciliate ancestry, the complex of dyskerin, NHP2, NOP10, and GAR1 that bind the H/ACA domain of human TR are thought to be the functional analog of the p65 chaperone in human telomerase (<xref ref-type="bibr" rid="B6">Berman et al., 2010</xref>; <xref ref-type="bibr" rid="B50">Roake and Artandi, 2020</xref>). Indeed, these H/ACA binding proteins are known to facilitate human TR folding by enabling the human CR4/5 domain to adopt a particular conformation that interacts with TERT (<xref ref-type="bibr" rid="B18">Egan and Collins, 2012</xref>; <xref ref-type="bibr" rid="B9">Chen et al., 2018</xref>). Interestingly, in <italic>Tb</italic>TR, the human H/ACA type snoRNP binding domain is replaced by a unique C/D box snoRNA domain (<xref ref-type="bibr" rid="B24">Gupta et al., 2013</xref>). In addition, TCAB1, another telomerase RNA-binding protein, was previously discovered as a part of human telomerase complex by mass spectrometry, which is important for intracellular trafficking (<xref ref-type="bibr" rid="B65">Venteicher et al., 2008</xref>) and regulating the folding of CR4/5 domain of human TR and telomerase activation. However, despite the fact that <italic>Tb</italic>TR possesses stage-specific structural changes in an active telomerase complex (<xref ref-type="bibr" rid="B14">Dey et al., 2021</xref>), major interactors in this complex remain unidentified.</p>
<p>In addition to the canonical function of the TERT protein to protect telomeric ends of chromosomes, emerging evidences also suggest that telomerase can contribute to oxidative stress response in a telomere-independent manner. TERT has been shown to shuttle to mitochondria under increased oxidative stress and influence processes related to DNA damage and cell death (<xref ref-type="bibr" rid="B53">Santos et al., 2004</xref>; <xref ref-type="bibr" rid="B2">Ahmed et al., 2008</xref>; <xref ref-type="bibr" rid="B31">Indran et al., 2011</xref>). There are 5 respiratory chain complexes in human mitochondria that can regulate redox processes and hTERT enhances complex I activity (<xref ref-type="bibr" rid="B3">Ale-Agha et al., 2021</xref>). Beyond this, very little is known about the involvement of mitochondrial proteins in TERT function. Interestingly, <italic>T. brucei</italic> protein <italic>Tb</italic>UMSBP2 (<xref ref-type="bibr" rid="B36">Klebanov-Akopyan et al., 2018</xref>), which binds to single-stranded G-rich sequence at the replication origins of the mitochondrial DNA of trypanosomatids, colocalizes with telomeres at the nucleus, but whether this activity is coordinated by telomerase mediated DNA repair is not known.</p>
<p>In order to gain a global view and mechanistic insight into telomerase function and regulation in <italic>T. brucei</italic>, we identified the interacting factors of <italic>T. brucei</italic> telomerase reverse transcriptase (<italic>Tb</italic>TERT) using an affinity-purification based mass spectrometry approach. We identified previously known and novel interactors of <italic>Tb</italic>TERT and validated several key interactions. Studying the interactome of <italic>Tb</italic>TERT lays the foundation for future studies of telomerase regulation in <italic>T. brucei</italic>.</p>
</sec>
<sec sec-type="materials|methods" id="s2">
<title>2 Materials and methods</title>
<sec id="s2-1">
<title>2.1 Culture of bloodstream form (BF) <italic>T. brucei</italic> cells</title>
<p>
<italic>T. brucei</italic> Lister strain 427 was used throughout this study. All BF cells were grown in HMI-9 media supplemented with 10% heat-inactivated Fetal Bovine Serum (FBS) at 37&#xb0;C and 5% CO<sub>2.</sub> <italic>T. brucei</italic> Lister 427 strain expressing the T7 polymerase and Tet repressor (single marker, AKA SM) (<xref ref-type="bibr" rid="B68">Wirtz et al., 1999</xref>) was grown in media containing 2&#xa0;&#x3bc;g/mL of G418; <italic>Tb</italic>TERT-FLAG-HA-HA (F2H) cells grown with 2&#xa0;&#x3bc;g/mL of G418, 0.1&#xa0;&#x3bc;g/mL Puromycin; <italic>Tb</italic>TR &#x2206;C/D box mutant cells were grown with 2&#xa0;&#x3bc;g/mL of G418, 4&#xa0;&#x3bc;g/mL of Hygromycin, 2.5&#xa0;&#x3bc;g/mL of Phleomycin, 5&#xa0;&#x3bc;g/mL of Blasticidin, 0.1&#xa0;&#x3bc;g/mL of Puromycin and 0.1&#xa0;&#x3bc;g/mL of Doxycycline to constitutively induce the <italic>Tb</italic>TR mutations.</p>
</sec>
<sec id="s2-2">
<title>2.2 Plasmids</title>
<p>The <italic>Tb</italic>TR WT gene without 3&#x2019; C/D box region (nt 841&#x2013;943) together with 400 bp upstream and 380 bp of downstream <italic>Tb</italic>TR flanking sequences were cloned into the pLew111 plasmid to generate pLew111-<italic>Tb</italic>TR &#x394;C/D box plasmid.</p>
</sec>
<sec id="s2-3">
<title>2.3 Generation of the BF <italic>T. brucei</italic> &#x2206;C/D box mutant strain</title>
<p>To generate the <italic>Tb</italic>TR &#x394;C/D box mutant strain, pLew111-<italic>Tb</italic>TR &#x394;C/D box plasmid (nt 841&#x2013;943 deleted) was digested with NotI and targeted to an rDNA spacer in the SM/<italic>Tb</italic>TR<sup>&#x2212;/&#x2212;</sup> cells under the phleomycin selection. Clones were confirmed by northern analysis. XhoI digested pSK-<italic>Tb</italic>TERT-3C-FLAG-HA-HA-<italic>PUR</italic> plasmid (<xref ref-type="bibr" rid="B14">Dey et al., 2021</xref>) was subsequently transfected into the same cells under the puromycin selection to generate the SM/<italic>Tb</italic>TR &#x394;C/D box/<italic>TbTERT</italic>
<sup>&#x2b;</sup>/<sup>F2H</sup> strain. Clones were confirmed by western and Southern blotting.</p>
</sec>
<sec id="s2-4">
<title>2.4 Immunopurification of <italic>T. brucei</italic> telomerase complexes</title>
<p>Immunoprecipitation of <italic>T. brucei</italic> telomerase was performed using a custom made anti-<italic>Tb</italic>TERT antibody (<xref ref-type="bibr" rid="B14">Dey et al., 2021</xref>) to purify native telomerase complexes from BF Wild-type (WT) and BF <italic>Tb</italic>TR &#x2206;C/D box cells. Approximately, 5 &#xd7; 10<sup>8</sup> cells/300&#xa0;mL were collected by centrifugation at 1900 RPM for 6&#xa0;min. Following centrifugation, cells were lysed by homogenization in 500&#xa0;&#xb5;L of 1X immunopurified (IP) lysis buffer (25&#xa0;mM Tris-HCl pH 7.5, 150&#xa0;mM KCl, 1&#xa0;mM EDTA, 10&#xa0;mM MgCl<sub>2</sub>, 0.5% IGEPAL CA630, 1X protease cocktail inhibitor, and 20 units of Ribolock RNase inhibitor). Lysate was then cleared of cell debris by centrifugation at 3000 RPM for 5&#xa0;min at 4&#xb0;C. The lysate was then pre-cleared by incubated with 50&#xa0;&#xb5;L of pre-washed Dynabeads protein G (10003D) for 1&#xa0;h at 4&#xb0;C on rotation. Pre-cleared lysates were then incubated overnight at 4&#xb0;C on rotation with 5&#xa0;&#xb5;g of a custom anti-<italic>Tb</italic>TERT antibody and an IgG antibody was added to the control (<xref ref-type="bibr" rid="B14">Dey et al., 2021</xref>). The next day, 50&#xa0;&#xb5;L of pre-washed Dynabeads protein G was added to the lysate antibody mixture and incubated at 4&#xb0;C for 2&#xa0;h on rotation. After incubation, the beads were collected in a magnetic stand and washed twice in &#xd7;1 IP lysis buffer. After washing, the bound protein was eluted off the beads by boiling in 100&#xa0;&#xb5;L of 1X SDS-PAGE dye for 5&#xa0;min at 95&#xb0;C. Eluted proteins were then stored in &#x2212;80&#xb0;C until further use. Each experiment was performed in biological triplicate (3 IPs and 3 IgG controls). Bound complexes were assayed for the presence of <italic>Tb</italic>TERT by using an anti-FLAG antibody as the BF WT cells were <italic>Tb</italic>TERT-FLAG-HA-HA tagged. Briefly, 4&#xa0;&#xb5;L of 100&#xa0;&#xb5;L of sample was loaded onto 4%&#x2013;12% Novex Tris-glycine gel (Invitrogen, XP04120BOX). Western blotting was done using an anti-FLAG antibody, diluted 1:500, and the VeriBlot for IP Detection Reagent (HRP, ab131366) diluted to 1:10,000. Detection was then done using Pierce ECL Plus Chemiluminescence kit (Thermo Fisher Scientific, 32,106). Imaging was then done using Bio-Rad ChemiDoc MP system.</p>
<p>Immunopurification was also performed using Pierce Anti-DYKDDDDK magnetic beads (A36797). Approximately 6 &#xd7; 10<sup>8</sup> cells/300&#xa0;mL were harvested and lysed in 300&#xa0;&#x3bc;L of immunopurified (IP) lysis buffer (25&#xa0;mM Tris-HCl pH 7.5, 150&#xa0;mM KCl, 25&#xa0;mM NaCl, 1&#xa0;mM EDTA, 10&#xa0;mM MgCl<sub>2</sub>, 0.5% IGEPAL CA630, 1&#xd7; protease cocktail inhibitor and 20 units of Ribolock RNase inhibitor). Lysate was cleared of debris by centrifugation at 3,000&#xa0;rpm for 5&#xa0;min at 4&#xb0;C and incubated with pre-washed 50&#xa0;&#x3bc;L of Pierce Anti-DYKDDDDK magnetic beads (A36797) at 4&#xb0;C for 2&#xa0;h with rotation. Following incubation, the beads were washed twice by ice cold IP buffer and once with ice cold DEPC water. The beads were then resuspended in 50&#xa0;&#x3bc;L of RNAse free water.</p>
</sec>
<sec id="s2-5">
<title>2.5 LC-MS/MS analysis</title>
<p>Proteins were separated by SDS-PAGE and Gel segments were cut and subjected to in-gel digestion using trypsin. Peptides were desalted using C18 ZipTips (Millipore). Peptides were analyzed on a Q-Exactive HF hybrid quadrupole-Orbitrap mass spectrometer (Thermo Fisher) equipped with an Easy LC 1200 UPLC liquid chromatography system (Thermo Fisher). Peptides were first trapped using trapping column Acclaim PepMap 100 (75&#xa0;uM x 2&#xa0;cm, nanoViper 2Pk, C18, 3&#xa0;&#x3bc;m, 100A), then separated using analytical column Acclaim PepMap RSLC (75&#xa0;um &#xd7; 25&#xa0;cm, nanoViper, C18, 2&#xa0;&#x3bc;m, 100A) (Thermo Fisher). The flow rate was 300&#xa0;nL/min, and a 120-min gradient was used. Peptides were eluted by a gradient from 3% to 28% solvent B (80% (v/v) acetonitrile/0.1% (v/v) formic acid) over 100&#xa0;min and from 28% to 44% solvent B over 20&#xa0;min, followed by a short wash at 90% solvent B. For DDA acquisition, the precursor scan was from mass-to-charge ratio (m/z) 375 to 1,600 and the top 20 most intense multiply charged precursors were selected for fragmentation. Peptides were fragmented with higher-energy collision dissociation (HCD) with normalized collision energy (NCE) 27.</p>
</sec>
<sec id="s2-6">
<title>2.6 LC-MS/MS data and statistical analysis</title>
<p>The resulting raw data files were searched against a concatenated library (TbruceiTREU927 release 32 databases with 11,202 entries) using MaxQuant (<xref ref-type="bibr" rid="B62">Tyanova et al., 2016</xref>). Carbamidomethyl Cysteine was set as a fixed modification. Oxidation of methionine and N-terminal acetylation were set as variable modifications. Tolerance for precursor ions was set to 4.5&#x2009;ppm and 20&#xa0;ppm for fragment ions. A maximum of two missed cleavages was allowed. MaxQuant was set to match in between runs and report LFQ. All other parameters were at the default setting. The proteinGroups.txt file generated by MaxQuant was further processed using Perseus. Reverse and possible contaminants were removed from the protein groups. Samples were separated into an experimental group consisting of the pull downs of isotype matched IgG (control) and a group consisting of the <italic>Tb</italic>TERT Immuno-Precipitation pull downs (3 IPs and 3 IgG controls). Protein groups were filtered to contain at least three quantifications in one experimental group. The remaining missing quantifications were imputed with random numbers from a normal distribution (width 0.3, shift &#x3d; 1.8). A two-sided Student&#x2019;s t-test was performed across replicates between each experimental group.</p>
</sec>
<sec id="s2-7">
<title>2.7 MS bioinformatics analysis</title>
<p>The mass spectrometry proteomic data was analyzed by a range of approaches. Volcano plot was generated using GraphPad Prism software version 9.3.1. The STRING database was used for classifying proteins based on functional categories and gene ontology (GO) terms. Protein-protein interaction network analysis was done using STRING version 11.5 (<ext-link ext-link-type="uri" xlink:href="https://string-db.org/">https://string-db.org/</ext-link>) and visualized by using the Cytoscape software version 3.9.1.</p>
</sec>
<sec id="s2-8">
<title>2.8 Structure-guided predictions</title>
<p>Proteins identified by mass spectrometry contained several hits that have very little primary sequence identity with proteins from other phyla, so their functional orthologs were not entirely evident from simple sequence homology. To identify whether structural homology exists between the local folds of these proteins and those reported in other organisms, we obtained predicted structure models of these <italic>T. brucei</italic> proteins from AlphaFold (<xref ref-type="bibr" rid="B34">Jumper et al., 2021</xref>) using their Uniprot IDs and then queried these &#x2018;PDB&#x2019; entries using programs PDBeFold (<xref ref-type="bibr" rid="B38">Krissinel and Henrick, 2004</xref>) and DaliLite (<xref ref-type="bibr" rid="B28">Holm and Rosenstr&#xf6;m, 2010</xref>). The top scoring and only relevant hit with a DaliLite Z score cut-off of &#x3e;2 is considered as biologically informative structural neighbor of the protein of interest (<xref ref-type="sec" rid="s10">Supplementary Table S1</xref>).</p>
</sec>
<sec id="s2-9">
<title>2.9 Western blotting and SDS-PAGE analysis</title>
<p>All <italic>Tb</italic>TERT western blots were done using either an anti-FLAG antibody (1:500) or a custom anti-<italic>Tb</italic>TERT C terminus antibody (1:500) unless otherwise indicated. Nucleolar protein 58 (NOP58) was detected using an anti-NOP58 antibody (Thermo Fisher Scientific, PA5-54321) diluted 1:500 and an anti-Rabbit HRP conjugated secondary antibody diluted to 1:10,000. To qualitatively check protein levels, 4&#xa0;&#xb5;L of IP eluate was separated on a 4%&#x2013;12% Novex Tris-glycine gel and stained with Coomassie Brilliant Blue R-250 Dye (Thermo Scientific, 20,278) for 30&#xa0;min. The gel was then destained until bands were visible in destain solution (40% MeOH, 10% acetic acid).</p>
</sec>
<sec id="s2-10">
<title>2.10 <italic>Tb</italic>TR detection and telomerase activity assay</title>
<p>
<italic>Tb</italic>TERT IP was performed as described in the methods <xref ref-type="sec" rid="s2-4">Section 2.4</xref>. To detect the presence of <italic>Tb</italic>TR in the IPed complex, total RNA was isolated from the protein G magnetic beads using the TRIzol reagent (Thermo Fisher Scientific, 15596026) following the manufacturers protocol. 100&#xa0;ng of isolated RNA was then used for cDNA synthesis utilizing the SuperScript II reverse transcriptase (Thermo Fisher Scientific, 18064022) following the manufacturers protocol. The generated cDNA was then used for qRT-PCR analysis using <italic>Tb</italic>TR specific primers (Fwd: CTG&#x200b;TGG&#x200b;AAA&#x200b;TTT&#x200b;GTC&#x200b;GTA&#x200b;AGT&#x200b;G, Rev: AGT&#x200b;AGG&#x200b;GTT&#x200b;AGG&#x200b;GAT&#x200b;CGT&#x200b;ATA&#x200b;G).</p>
<p>To determine the activity of the Immunopurified <italic>T. brucei</italic> telomerase complex, a modified version of the exponential isothermal amplification of telomere repeat (EXPIATR) assay was performed (<xref ref-type="bibr" rid="B61">Tian and Weizmann, 2013</xref>; <xref ref-type="bibr" rid="B14">Dey et al., 2021</xref>)Briefly, A master mix was prepared on ice consisting of Nicking Telomerase Substrate (NTS, GTG&#x200b;CGT&#x200b;GAG&#x200b;AGC&#x200b;TCT&#x200b;TCC&#x200b;AAT&#x200b;CCG&#x200b;TCG&#x200b;AGC&#x200b;AGA&#x200b;GTT), Nicking Probe (NP, AGC&#x200b;AGG&#x200b;AAG&#x200b;CGC&#x200b;TCT&#x200b;TCC&#x200b;TGC&#x200b;TCC&#x200b;CTA&#x200b;ACC&#x200b;CTA&#x200b;ACC&#x200b;C), 1X EXPIATR buffer (30&#xa0;mM Tris-HCl, pH 8.3, 1.5 mM MgCl2, 100&#xa0;mM KCl, 1&#xa0;mM EGTA, 0.05% v/v Tween20), 200&#xa0;&#xb5;M dNTPs, Bst 2.0 Warm start DNA polymerase (0.96 units) and Nt. BspQ1 NEase (5 units). 17&#xa0;&#x3bc;L of the master mix was aliquoted to PCR tubes containing, 3&#xa0;&#xb5;L of anti-FLAG bead-bound <italic>T. brucei</italic> telomerase, RNase A treated or heat-inactivated telomerase RNP bound beads, telomerase positive control (TPC8, GTG&#x200b;CGT&#x200b;GAG&#x200b;AGC&#x200b;TCT&#x200b;TCC&#x200b;AAT&#x200b;CCG&#x200b;TCG&#x200b;AGC&#x200b;AGA&#x200b;GTT&#x200b;AGG&#x200b;GTT&#x200b;AGG&#x200b;GTT&#x200b;AGG&#x200b;GTT&#x200b;AGG&#x200b;GTT&#x200b;AGG&#x200b;GTT&#x200b;AGG&#x200b;GTT&#x200b;AGG&#x200b;GTT&#x200b;AGG&#x200b;G) (0.5&#xa0;&#x3bc;M) and blank beads as a negative control. Telomerase activity was initiated by initial incubation of tubes at 28&#xb0;C for 45&#xa0;min for Nicking telomerase substrate (NTS) extension followed by amplification of resultant telomerase products at 55&#xb0;C for 30&#xa0;min. The amplified products were then analyzed on 12% Native PAGE gel by loading 10&#xa0;&#x3bc;L of the reaction mixture.</p>
</sec>
</sec>
<sec sec-type="results" id="s3">
<title>3 Results</title>
<sec id="s3-1">
<title>3.1 Affinity-purification mass spectrometry (AP-MS) of BF <italic>T. brucei</italic> telomerase reverse transcriptase</title>
<p>Characterizing the global interactors of a protein of interest can be done through affinity-purification mass spectrometry (AP-MS). Identifying the interactome of a protein is key in understanding its function in the cell and how it is regulated. To identify the global protein interactors of <italic>T. brucei</italic> telomerase, we utilized AP-MS to identify the global interactome of <italic>Tb</italic>TERT at the BF stage. We first immunopurified (IP) <italic>Tb</italic>TERT using a custom anti-<italic>Tb</italic>TERT antibody along with its associated proteins and performed LC-MS/MS (<xref ref-type="fig" rid="F1">Figure 1A</xref>). For immuno-affinity purification, 500&#xa0;ul of lysate containing 1&#xa0;mg of total protein was used per IP sample. <italic>Tb</italic>TERT was pulled down from the lysate using a custom anti-C terminus <italic>Tb</italic>TERT antibody (<xref ref-type="bibr" rid="B14">Dey et al., 2021</xref>). In addition to verifying the specificity of the custom antibody for binding to <italic>Tb</italic>TERT, the presence of some non-specific cross-reactive bands were also observed. The presence of the immunopurified <italic>Tb</italic>TERT was confirmed using western blotting and SDS-PAGE analysis (<xref ref-type="fig" rid="F1">Figures 1B&#x2013;D</xref>). Immunoblot analysis (anti-FLAG antibody) of the IP fractions from <italic>Tb</italic>TERT-F2H cells showed that <italic>Tb</italic>TERT was enriched in the pulldown products from anti-<italic>Tb</italic>TERT C terminus antibody IPs but not from control groups. The anti-<italic>Tb</italic>TERT C-terminus antibody IP samples were then subjected to SDS-PAGE and in-gel protease digestion, followed by mass spectrometry as described in &#x2018;Materials and Methods&#x2019;. To further validate the presence of telomerase components in the IP, RNA was extracted from IP beads and subjected to qRT-PCR analysis to confirm the presence of the telomerase RNA in the complex (<xref ref-type="fig" rid="F1">Figure 1E</xref>). To determine if the immunopurified telomerase complex was catalytically active, we performed a telomerase activity assay (EXPIATR) using the IPed complex (<xref ref-type="fig" rid="F1">Figure 1F</xref>). The result confirmed that the immunopurified <italic>T. brucei</italic> telomerase complex was catalytically active. To independently validate our proteomic screen, another set of affinity enrichment of <italic>Tb</italic>TERT protein using an anti-FLAG antibody was performed in duplicates in <italic>Tb</italic>TERT-F2H cells (two biological replicates) and screened for known <italic>Tb</italic>TERT interactors. Both the <italic>Tb</italic>TERT IP-MS and <italic>Tb</italic>TERT FLAG pulldown MS data were compared. Since <italic>Tb</italic>TERT and several other proteins that were previously linked to telomerase were identified in both of the FLAG and C-terminus IP mass spec data sets (<xref ref-type="fig" rid="F2">Figure 2</xref>; <xref ref-type="sec" rid="s10">Supplementary Table S1</xref>), it was apparent that the ribonucleoprotein complex identified by this approach is biologically relevant to telomerase function.</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Affinity-purification mass spectrometry of bloodstream form <italic>T. brucei</italic> telomerase reverse transcriptase. <bold>(A)</bold> Experimental workflow for proteomic analysis. BF <italic>T. brucei</italic> cells expressing a FLAG tagged version of <italic>Tb</italic>TERT were grown and <italic>Tb</italic>TERT complexes were purified using a custom anti-<italic>Tb</italic>TERT C terminus antibody. An IgG isotype antibody was used as a control. Purified <italic>Tb</italic>TERT complexes were then digested with trypsin. These peptides were then analyzed by LC-MS/MS. <bold>(B)</bold> Western blot confirming the presence of immunopurified <italic>Tb</italic>TERT. IP samples were obtained and run on SDS-PAGE gels and immunoblotted with anti-FLAG antibody to detect <italic>Tb</italic>TERT. <bold>(C)</bold> Western blot confirming the presence of <italic>Tb</italic>TERT. IP samples were obtained and run on SDS-PAGE gels and immunoblotted with an anti-<italic>Tb</italic>TERT C terminus antibody to detect <italic>Tb</italic>TERT. <bold>(D)</bold> SDS-PAGE analysis of immunopurified <italic>Tb</italic>TERT. A small aliquot was also resolved on SDS-PAGE and stained with Coomassie stain to qualitatively check <italic>Tb</italic>TERT protein levels. <bold>(E)</bold> RT-qPCR detection of <italic>Tb</italic>TR from Immunopurified <italic>Tb</italic>TERT complexes. <bold>(F)</bold> Telomerase activity of the bead-bound telomerase enzyme was analyzed by telomerase primer extension assay.</p>
</caption>
<graphic xlink:href="fcell-11-1110423-g001.tif"/>
</fig>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>
<bold>(A)</bold> Volcano plot was performed with an <italic>x</italic>-axis representing the difference in logarithmic protein intensities between the <italic>Tb</italic>TERT immunoprecipitation elution and the isotype matched IgG control (Elution and Control experimental groups). The <italic>y</italic>-axis is the negative log of the two-sided Student&#x2019;s t-test. The volcano plot serves as a visual representation of the protein groups that are significantly enriched between the elution and control groups. These enriched groups contain the bait protein <italic>Tb</italic>TERT and several candidates interacting with a <italic>p</italic>-value &#x2264; 0.05. <bold>(B)</bold> Protein-protein interaction network of relevant <italic>Tb</italic>TERT hits identified by MS. Network was generated using the STRING database and visualized using Cytoscape. Colors of nodes represent the protein&#x2019;s biological function. The thickness of the lines denotes the strength of the interaction (confidence PPI, threshold: 0.4, medium confidence).</p>
</caption>
<graphic xlink:href="fcell-11-1110423-g002.tif"/>
</fig>
</sec>
<sec id="s3-2">
<title>3.2 Proteomic analysis of BF <italic>T. brucei</italic> telomerase reverse transcriptase</title>
<p>We identified 1,056 proteins with 2 or more peptides. After stringent filtering of this dataset for those proteins highly enriched (Log<sub>2</sub>(fold change) &#x3e; 1.9) in the IP vs. control (<xref ref-type="sec" rid="s10">Supplementary Table S1</xref>), 66 high-confidence proteins remained. To study the interactome of <italic>Tb</italic>TERT, the relative abundance (log<sub>2</sub>(fold change)) and statistical significance -log<sub>10</sub>(<italic>P</italic>-value) of the proteins from the IP samples and controls were calculated (3 IP samples and 3 IgG controls samples) (<xref ref-type="fig" rid="F2">Figure 2A</xref>). This resulted in the enrichment of 56 proteins for the anti-<italic>Tb</italic>TERT IP samples (<xref ref-type="sec" rid="s10">Supplementary Table S2</xref>). The protein samples that were significantly enriched in the IP samples <italic>versus</italic> the controls (Student&#x2019;s t-test, -log<sub>10</sub>(<italic>P</italic>-value) &#x3e; 1.3) included both nuclear and mitochondrial proteins that have previously been shown to interact with TERT or play a role in telomere maintenance, such as <italic>T. brucei</italic> telomerase reverse transcriptase (<italic>Tb</italic>TERT, Tb927.11.10190), yeast telomerase cell cycle turnover-related (anaphase promoting complex) proteins, CDC16 (Tb927.6.2150) and CDC27 (Tb927.10.10330) homologs (<xref ref-type="bibr" rid="B55">Sealey et al., 2011</xref>; <xref ref-type="bibr" rid="B19">Ferguson et al., 2013</xref>), mitochondrial stress-response protein, human HSP60 homolog (Tb927.11.15040) which is known to accumulate with hTERT in the same fractions of human mitochondria (<xref ref-type="bibr" rid="B56">Sharma et al., 2012</xref>), Splicing factor 3B subunit 1 (SF3B1) homolog (Tb927.11.11850) involved in various cellular functions including DNA damage response (<xref ref-type="bibr" rid="B60">Te Raa et al., 2015</xref>) and telomere maintenance (<xref ref-type="bibr" rid="B66">Wang et al., 2016</xref>), damage specific DNA binding protein 1 (DDB1) homolog (Tb927.6.5110), involved in ubiquitin-mediated TERT protein degradation (<xref ref-type="bibr" rid="B35">Jung et al., 2013</xref>), and several other proteins involved in telomerase and telomere metabolism (selected proteins shown in <xref ref-type="fig" rid="F2">Figure 2A</xref>; <xref ref-type="table" rid="T1">Table 1</xref>).</p>
<table-wrap id="T1" position="float">
<label>TABLE 1</label>
<caption>
<p>Significantly enriched proteins identified in <italic>Tb</italic>TERT complex.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left">Protein</th>
<th align="left">Accession number</th>
<th align="left">Spectral counts</th>
<th align="left">Unique peptides (UniProtKB)</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">
<italic>Tb</italic>TERT</td>
<td align="left">Q383RO</td>
<td align="left">10</td>
<td align="left">5</td>
</tr>
<tr>
<td align="left">HSP60</td>
<td align="left">Q381Tl</td>
<td align="left">6</td>
<td align="left">5</td>
</tr>
<tr>
<td align="left">DnaJ</td>
<td align="left">Q38C15</td>
<td align="left">19</td>
<td align="left">5</td>
</tr>
<tr>
<td align="left">APC3</td>
<td align="left">Q389U4</td>
<td align="left">21</td>
<td align="left">6</td>
</tr>
<tr>
<td align="left">CDC16</td>
<td align="left">Q584Ul</td>
<td align="left">30</td>
<td align="left">12</td>
</tr>
<tr>
<td align="left">SF3Bl</td>
<td align="left">Q382Z6</td>
<td align="left">26</td>
<td align="left">14</td>
</tr>
<tr>
<td align="left">DDBl</td>
<td align="left">Q586I3</td>
<td align="left">21</td>
<td align="left">13</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>To highlight the connectivity of candidate <italic>Tb</italic>TERT interactors, we used the STRING database and Cytoscape to generate a functional protein-protein interaction network of <italic>Tb</italic>TERT (<xref ref-type="fig" rid="F2">Figure 2B</xref>; <xref ref-type="sec" rid="s10">Supplementary Figure S1</xref>). To further determine the functions of proteins in the network, STRING GO analysis was done and proteins were grouped by biological process, and cellular component (<xref ref-type="fig" rid="F3">Figures 3A, B</xref>). Terms for biological process that were enriched included, telomere maintenance by telomerase, cell cycle control, DNA repair, and response to stress. Enriched cellular component terms included, box C/D snoRNP complex, DNA replication factor C, anaphase-promoting complex, and cullin-RING ubiquitin ligase complex. Notably, proteins that are important for telomerase RNA biogenesis, processing and trafficking were significantly enriched in these GO terms.</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>GO analysis of <italic>T. brucei</italic> TERT interactome. STRING GO analysis <bold>(A)</bold> Enrichment by Biological process. The top 15 enriched GO terms are shown. <bold>(B)</bold> enrichment by Cellular component. The top 9 enriched GO terms are shown.</p>
</caption>
<graphic xlink:href="fcell-11-1110423-g003.tif"/>
</fig>
<p>An independent set of IP-MS using an anti-FLAG antibody to IP <italic>Tb</italic>TERT also validated a majority of the proteins identified in the mass spec run described above from the anti-C terminus <italic>Tb</italic>TERT IP because these proteins were identified with both IP approaches. A false discovery rate (FDR) of 1% was used as cut off for this data (<xref ref-type="sec" rid="s10">Supplementary Table S3</xref>).</p>
</sec>
<sec id="s3-3">
<title>3.3 Known and novel interactors are part of the active telomerase RNP in <italic>T. brucei</italic>
</title>
<p>Homologs of telomerase-associated proteins which are known regulators of telomerase functions were found to be part of the IP telomerase complex in <italic>T. brucei</italic>. Typically, three types of known telomerase-associated proteins were reported to co-purify with TERT. The foremost of the three are the telomerase RNA-binding proteins that are involved in TR biogenesis, trafficking and TR-TERT assembly. These include, for example, dyskerin in vertebrates (<xref ref-type="bibr" rid="B41">Mitchell and Collins, 2000</xref>; <xref ref-type="bibr" rid="B42">Mochizuki et al., 2004</xref>), Sm proteins in yeasts (<xref ref-type="bibr" rid="B59">Tang et al., 2012</xref>), and La-motif proteins, such as p65, in ciliates (<xref ref-type="bibr" rid="B58">Singh et al., 2012</xref>). Interestingly, dyskerin binding H/ACA domain of human TR is replaced by a novel C/D box domain in <italic>T. brucei</italic> (<xref ref-type="bibr" rid="B24">Gupta et al., 2013</xref>). Several unique C/D box snoRNA binding proteins (snoRNPs) were identified in our <italic>Tb</italic>TERT immunopurified complex which are described in the next section. In addition, a <italic>T. brucei</italic> La protein, Tb927.10.2370, which shows 24% amino acid sequence identity and a Z-score of 8.6 with <italic>Tetrahymena thermophila</italic>, TR binding protein p65 was also identified in the IP-MS. Telomerase RNP assembly also requires molecular chaperones, such as AAA&#x2b; family of ATPases, known as Pontin and Reptin, which can directly interact with TERT and play critical roles in telomerase RNP accumulation (<xref ref-type="bibr" rid="B65">Venteicher et al., 2008</xref>). Both the Pontin (Tb927.4.1270) and Reptin (Tb927.4.2000) homologs, annotated as RuvB-like DNA helicases in the <italic>T. brucei</italic> genome database, were also identified by this <italic>Tb</italic>TERT AP-MS analysis. Additionally, another AAA&#x2b; ATPase protein, a yeast CDC48 homolog, Tb927.10.5770, was also identified. CDC48, which was previously identified in a molecular complex that recognized and bound ubiquitinated proteins (<xref ref-type="bibr" rid="B54">Schuberth et al., 2004</xref>), was also found to be associated with yeast telomerase as a novel regulator of telomere length homeostasis. Notably, TERT turnover is dependent on ubiquitin-proteasome mediated degradation process (<xref ref-type="bibr" rid="B35">Jung et al., 2013</xref>) and therefore proteins that are important for ubiquitination were previously identified in the telomerase complexes, such as several isoforms of E3 ubiquitin ligases (<xref ref-type="bibr" rid="B39">Lin et al., 2015</xref>). Interestingly, several ubiquitin-family proteins were also identified in the IP-MS data including ubiquitin ligases, although the roles of these proteins in <italic>T. brucei</italic> telomerase biology remains uncertain until the ubiquitination status of <italic>Tb</italic>TERT is determined.</p>
<p>Mammalian studies have identified chaperone proteins p23 and HSP90 as two important proteins that are physically and functionally associated with telomerase activity (<xref ref-type="bibr" rid="B29">Holt et al., 1999</xref>). The proteomic mapping also identified a mammalian HSP90 homolog, Tb927.3.3580, with enrichment of several unique peptides in <italic>Tb</italic>TERT IP samples identified by MS. Poly(A)-specific ribonuclease (PARN) is a 3&#x2032;-exoribonuclease that is known to play important role in the maturation of telomerase RNA (<xref ref-type="bibr" rid="B43">Moon et al., 2015</xref>). A <italic>T. brucei</italic> homolog of PARN, Tb927.9.13510 was identified in this proteomic mapping data that may relate with the fact that <italic>T. brucei</italic> telomerase RNA is a Pol II transcript (<xref ref-type="bibr" rid="B52">Sandhu et al., 2013</xref>) that may require PARN processing for maturation. All these known telomerase homologs of <italic>T. brucei</italic> are listed in <xref ref-type="sec" rid="s10">Supplementary Table S1</xref>. In terms of proteomic identification, it should be noted that several of the above proteins were identified in the range of low scoring functions or higher FDR%, however, these proteins are identified in all four of the biological replicates analyzed by AP-MS and therefore could be biologically relevant. Importantly, all the above proteins identified were part of the IP sample that was able to extend <italic>T. brucei</italic> telomeric repeats using synthetic TTAGGG as substrates in activity assays (<xref ref-type="fig" rid="F1">Figure 1F</xref>), indicating that the proteins in this IP are potentially part of an active telomerase complex.</p>
</sec>
<sec id="s3-4">
<title>3.4 The unique C/D box domain in <italic>T. brucei</italic> telomerase RNA is bound by snoRNPs</title>
<p>In contrast to hTR, the telomerase RNA in <italic>T. brucei</italic> contains a unique C/D snoRNA-like domain (<xref ref-type="fig" rid="F4">Figure 4A</xref> bottom). Core C/D box RNPs, like NOP58, have previously been shown to interact with <italic>Tb</italic>TR (<xref ref-type="bibr" rid="B24">Gupta et al., 2013</xref>). NOP58 is a 57&#xa0;KDa protein that contains a coiled-coil (CC) domain and a NOP domain (<xref ref-type="fig" rid="F4">Figure 4A</xref> top). NOP58 is highly conserved across eukaryotes and plays important roles in ribosomal RNA (rRNA) processing (<xref ref-type="bibr" rid="B4">Barth et al., 2008</xref>). In our AP-MS analysis of <italic>Tb</italic>TERT, we identified three core C/D box binding proteins: NOP58, NOP56, and Fibrillarin (NOP1) (<xref ref-type="table" rid="T2">Table 2</xref>; <xref ref-type="sec" rid="s10">Supplementary Table S3</xref>). To validate the interaction with NOP58, we performed a co-immunoprecipitation (Co-IP) assay of <italic>Tb</italic>TERT and detected <italic>Tb</italic>TERT and NOP58 through western blotting (<xref ref-type="fig" rid="F4">Figure 4B</xref> top). For further confirmation of this interaction, we performed Co-IPs of <italic>Tb</italic>TERT in both WT and &#x2206;C/D box mutant cell lines. In the WT cells, NOP58 is present in the IP product, while in the &#x2206;C/D mutant cells, the interaction with NOP58 is greatly diminished (<xref ref-type="fig" rid="F4">Figure 4B</xref> bottom). This data supports the fact that the C/D box motif is important for the interaction between <italic>Tb</italic>TR and NOP58.</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>NOP58 interacts with the <italic>T. brucei</italic> telomerase complex. <bold>(A)</bold> Domain structure of human NOP58. Predicted secondary structure models for <italic>T. brucei</italic> and human NOP58 obtained from AlphaFold (<xref ref-type="bibr" rid="B34">Jumper et al., 2021</xref>) Predicted protein structures are shown in the same orientation. Dark blue represents a very high model confidence (pLDDT &#x3e;90), light blue confident (90 &#x3e; pLDDT &#x3e;70), yellow low confidence (70 &#x3e; pLDDT &#x3e;50), orange very low confidence (pLDDT &#x3c;50). Secondary structure model of <italic>T. brucei</italic> telomerase RNA. The C/D box binding motif is highlighted. [<bold>(B)</bold>, top] Co-IP assay using WT <italic>T. brucei</italic> cell lysate. IP antibody: anti-<italic>Tb</italic>TERT C terminus; Western blot antibodies: anti-FLAG and anti-NOP58. [<bold>(B)</bold>, bottom] Co-IP using both WT and &#x2206;C/D box mutant cells. IP antibody: anti-<italic>Tb</italic>TERT C terminus; western blot antibodies: anti-FLAG and anti-NOP58.</p>
</caption>
<graphic xlink:href="fcell-11-1110423-g004.tif"/>
</fig>
<table-wrap id="T2" position="float">
<label>TABLE 2</label>
<caption>
<p>Core C/D snoRNPs identified in <italic>Tb</italic>TERT complex.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left">Protein</th>
<th align="left">Accession number (UniProtKB)</th>
<th align="left">Spectral counts</th>
<th align="left">Unique peptides</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">NOP58</td>
<td align="left">Q38F23</td>
<td align="left">25</td>
<td align="left">12</td>
</tr>
<tr>
<td align="left">NOP56</td>
<td align="left">Q580Z5</td>
<td align="left">24</td>
<td align="left">10</td>
</tr>
<tr>
<td align="left">Fibrillarin/NOPl</td>
<td align="left">Q388EO</td>
<td align="left">8</td>
<td align="left">3</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
</sec>
<sec sec-type="discussion" id="s4">
<title>4 Discussion</title>
<p>Eukaryotic microbes, such as <italic>T. brucei</italic>, rely on constitutive telomerase activity to sustain their proliferation in their hosts and to maintain the integrity of their subtelomeric virulence genes. Studying these interacting partners of telomerase in <italic>T. brucei</italic> is necessary to characterize the mechanism of telomerase mediated telomere maintenance in these parasites. Like any other RNA component of telomerase, <italic>T. brucei</italic> telomerase RNA in the holoenzyme acts as a structural scaffold that accessory proteins can bind to (<xref ref-type="bibr" rid="B13">Dey and Chakrabarti, 2018</xref>). Interacting proteins of telomerase in <italic>T. brucei</italic> have not been extensively studied. We have utilized a mass spectrometry approach to identify and characterize endogenous interactions of <italic>Tb</italic>TERT in BF <italic>T. brucei</italic> cells. However, characterization of dynamic RNA-protein interactions like the one in telomerase complex comes with a challenge &#x2013; that several of these interaction partners could be only transiently bound and therefore may not represent the complex interactions in its entirety. Non-etheless, this affinity purification based proteomic characterization of <italic>T. brucei</italic> telomerase RNP complex provides a global view of the cellular protein interactome landscape that can be used for in-depth functional characterization of telomerase complex proteins in parasites.</p>
<p>Some potential limitations of this study are the use of affinity purification methods. These methods are good at isolating strong interactions of our bait protein <italic>Tb</italic>TERT, but as mentioned above, weaker or more transient interactions may be missed by this analysis. Also, proteins of low abundance, such as TERT, could be difficult to enrich in affinity purified complexes even by targeted approaches like RNA-targeted APEX based proteomic approach recently employed for human telomerase (<xref ref-type="bibr" rid="B25">Han et al., 2020</xref>). For that reason, it is possible that several <italic>Tb</italic>TR and <italic>Tb</italic>TERT associated proteins that are identified in this proteomic screen showed low level of enrichment in the IP complex, as evident from MS. Since IP experiments using MS provide a sensitive and accurate way of characterizing protein complexes, the quality of antibody may also play a role in isolating and analyzing specific interactions. The custom anti-<italic>Tb</italic>TERT polyclonal antibody used in the IP experiments was cross-reactive to other proteins (data not shown), however, the binding specificity to the endogenous bait protein <italic>Tb</italic>TERT was successfully confirmed using Co-IP and Western blot as <italic>Tb</italic>TERT was detected as a single, discrete band. Additionally, detection of the telomerase-associated proteins in all biological replicates added confidence to the current approach.</p>
<p>Our proteomics experiments also identified proteins that have no known relationship with telomerase and therefore these hits could be false positives or newly discovered interactors of <italic>Tb</italic>TERT. For example, an RNA cytidine acetyltransferase, NAT10 homolog (Tb927.5.2530) was found enriched in all proteomic datasets. NAT10 was previously shown to have predominantly nucleolar localization, association with human telomerase, and is primarily involved in telomerase RNA biogenesis (<xref ref-type="bibr" rid="B21">Fu and Collins, 2007</xref>). One more example is the putative NOT1 deadenylase (Tb927.10.1510), part of the CCR4-NOT deadenylase complex, which plays important regulatory roles both at the transcriptional and post-transcriptional levels, such as heterochromatic repression of sub-telomeric genes in fission yeast (<xref ref-type="bibr" rid="B11">Cotobal et al., 2015</xref>) and rapid deadenylation of m6A-containing RNAs by the CCR4&#x2013;NOT deadenylase complex in mammalian cells (<xref ref-type="bibr" rid="B17">Du et al., 2016</xref>). Given that a majority of expressed virulence genes (<italic>VSGs</italic>) in <italic>T. brucei</italic> are subtelomeric (<xref ref-type="bibr" rid="B51">Saha et al., 2020</xref>) and human telomerase RNAs are known to contain m6A signatures (<xref ref-type="bibr" rid="B25">Han et al., 2020</xref>), the role of Tb927.10.1510 remains unexplored but relevant to <italic>T. brucei</italic> telomere biology.</p>
<p>In our proteomics screen, several mitochondrial proteins were highly enriched, including <italic>Tb</italic>UMSBP2, which has been shown to associate with telomeres in <italic>T. brucei</italic> (<xref ref-type="bibr" rid="B36">Klebanov-Akopyan et al., 2018</xref>). This protein&#x2019;s canonical function is the replication and segregation of <italic>T. brucei&#x2019;s</italic> mitochondrial DNA, but it has been shown to also play a role in chromosome end protection in <italic>T. brucei</italic> (<xref ref-type="bibr" rid="B36">Klebanov-Akopyan et al., 2018</xref>)<italic>.</italic> Significantly enriched GO terms from the analysis of the <italic>Tb</italic>TERT interactome included, telomere maintenance <italic>via</italic> telomerase, cell cycle control, and chaperone binding. Similar terms and protein interactors have been previously observed for <italic>Saccharomyces cerevisiae</italic> telomerase (<xref ref-type="bibr" rid="B39">Lin et al., 2015</xref>). Telomere maintenance <italic>via</italic> telomerase is consistent with <italic>Tb</italic>TERT&#x2019;s known role in extending telomeres (<xref ref-type="bibr" rid="B16">Dreesen et al., 2005</xref>). Enrichment of proteins involved in cell cycle control highlight potential factors involved in the cell cycle specific regulation of <italic>Tb</italic>TERT. Specifically, APC3 and CDC16 were significantly enriched in the <italic>Tb</italic>TERT interactome. APC3 and CDC16 are core components of the anaphase-promoting complex (APC), which is a 1.5&#xa0;MDa ubiquitin ligase complex that regulates sister-chromatid separation and the cells exit from mitosis (<xref ref-type="bibr" rid="B46">Peters, 2006</xref>). In <italic>S. cerevisiae</italic>, the APC has been shown to degrade the telomerase recruitment subunit, Est1p to regulate telomere maintenance (<xref ref-type="bibr" rid="B19">Ferguson et al., 2013</xref>). Whether an analogous mechanism exists in <italic>T. brucei</italic> remains to be explored.</p>
<p>Chaperone proteins such as DnaJ, which is a major co-chaperone for HSP70 and HSP60 were also found to be significantly enriched in the <italic>Tb</italic>TERT interactome. Both DnaJ and HSP60 have previously been found to associate with human telomeres (<xref ref-type="bibr" rid="B45">Nittis et al., 2010</xref>). HSP60 is a predominately mitochondrial chaperone, where it works to maintain protein homeostasis (<xref ref-type="bibr" rid="B7">Caruso Bavisotto et al., 2020</xref>). In human cells, TERT has been previously reported to localize to the mitochondria and guard cells against oxidative stress (<xref ref-type="bibr" rid="B2">Ahmed et al., 2008</xref>). Human TERT has also been shown to associate with HSP60 and act independently of the TR in the mitochondria (<xref ref-type="bibr" rid="B56">Sharma et al., 2012</xref>). <italic>Tb</italic>TERT&#x2019;s association with HSP60 suggests a pool of <italic>T. brucei</italic> telomerase may also be localized in the mitochondrion.</p>
<p>In addition to proteins involved in cell cycle control and chaperones, core C/D snoRNP proteins, NOP58, NOP56, and Fibrillarin (NOP1) were also identified in the <italic>Tb</italic>TERT interactome. Our co-IP western blot data validates the interaction of NOP58 with the <italic>T. brucei</italic> telomerase complex. NOP58 interacts with NOP56 and NOP1 to form a subcomplex, which participates in rRNA processing (<xref ref-type="bibr" rid="B4">Barth et al., 2008</xref>). Core C/D box binding proteins, like NOP58, have been previously shown to interact with the <italic>Tb</italic>TR (<xref ref-type="bibr" rid="B24">Gupta et al., 2013</xref>). Our study supports these findings and shows that NOP58 interacts with the C/D box motif in the <italic>Tb</italic>TR. The C/D box motif in <italic>Tb</italic>TR is unique and lacking in higher eukaryotes. The TR in <italic>Leishmania</italic> also contains a C/D box motif (<xref ref-type="bibr" rid="B64">Vasconcelos et al., 2014</xref>). The conservation of the C/D box motif in the TR of these parasites could indicate a novel mechanism for telomerase biogenesis and processing, mediated by C/D box binding proteins, in these kinetoplastid parasites.</p>
<p>The work described here provides the first analysis of the <italic>Tb</italic>TERT interactome. We have identified previously known and novel interactors of <italic>Tb</italic>TERT. We were able to confirm NOP58&#x2019;s interaction with the <italic>T. brucei</italic> telomerase complex, which supports earlier studies (Gupta el al., 2013). Taken together our study lays the foundation for future studies into the mechanism of telomerase mediated telomere maintenance in <italic>T. brucei</italic>. Future improvements are needed to develop a telomerase RNA -tagged proteomic mapping approach in <italic>T. brucei</italic> to validate endogenous interactions identified by this method and also detect new RNA-specific interactions. Future studies should also benefit from investigating interactomes from other <italic>T. brucei</italic> developmental stages since it appears from our recent study that <italic>T. brucei</italic> telomerase function is developmentally regulated (<xref ref-type="bibr" rid="B14">Dey et al., 2021</xref>). Therefore, characterizing stage-specific interactomes can provide novel insights into regulatory mechanisms that can affect rate of proliferation and telomerase activity in <italic>T. brucei</italic>.</p>
</sec>
</body>
<back>
<sec sec-type="data-availability" id="s5">
<title>Data availability statement</title>
<p>The data presented in the study are deposited in the ProteomeXchange (PRIDE) repository, accession number: PXD038235.</p>
</sec>
<sec id="s6">
<title>Author contributions</title>
<p>JD, BL, and KC designed experiments. JD, AR, Nitika, and AS conducted experiments. S-LX, AT, BL, and KC contributed critical reagents and suggestions. JD, AR, Nitika, and DW analyzed data. JD and KC wrote the manuscript. All authors revised and approved the final manuscript.</p>
</sec>
<sec id="s7">
<title>Funding</title>
<p>This work was funded by National Science Foundation (NSF) grant MCB-1764273 to KC, and MCB-1615896 to BL and by National Institute of Health (NIH) grant 1R15AI166764-01A1 to KC, and NIH grant 1R01GM139885 to AWT.</p>
</sec>
<ack>
<p>We thank KC lab members at UNC Charlotte and Li lab members at the Cleveland State University for their help and support with this work and Dr. Jun-tao Guo from the Department of Bioinformatics and Genomics at UNC Charlotte for help with structure-based prediction analysis using PDBeFold and DaliLite. Figures were created using <ext-link ext-link-type="uri" xlink:href="http://BioRender.com">BioRender.com</ext-link>.</p>
</ack>
<sec sec-type="COI-statement" id="s8">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s9">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="s10">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fcell.2023.1110423/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fcell.2023.1110423/full&#x23;supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="Table2.xlsx" id="SM1" mimetype="application/xlsx" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Image1.tif" id="SM2" mimetype="application/tif" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Table3.docx" id="SM3" mimetype="application/docx" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Table1.xlsx" id="SM4" mimetype="application/xlsx" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Afrin</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Gaurav</surname>
<given-names>A. K.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Pan</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>B (</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Tb RAP1 has an unusual duplex DNA binding activity required for its telomere localization and VSG silencing</article-title>. <source>Sci. Adv.</source> <volume>6</volume> (<issue>38</issue>), <fpage>eabc4065</fpage>. <pub-id pub-id-type="doi">10.1126/sciadv.abc4065</pub-id>
</citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ahmed</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Passos</surname>
<given-names>J. F.</given-names>
</name>
<name>
<surname>Birket</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>Beckmann</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Brings</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Peters</surname>
<given-names>H.</given-names>
</name>
<etal/>
</person-group> (<year>2008</year>). <article-title>Telomerase does not counteract telomere shortening but protects mitochondrial function under oxidative stress</article-title>. <source>J. Cell Sci.</source> <volume>121</volume> (<issue>7</issue>), <fpage>1046</fpage>&#x2013;<lpage>1053</lpage>. <pub-id pub-id-type="doi">10.1242/jcs.019372</pub-id>
</citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ale-Agha</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Jakobs</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Goy</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Zurek</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Rosen</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Dyballa-Rukes</surname>
<given-names>N.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Mitochondrial telomerase reverse transcriptase protects from myocardial ischemia/reperfusion injury by improving complex I composition and function</article-title>. <source>Circulation</source> <volume>144</volume> (<issue>23</issue>), <fpage>1876</fpage>&#x2013;<lpage>1890</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.120.051923</pub-id>
</citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barth</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Shalem</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Hury</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Tkacz</surname>
<given-names>I. D.</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>X. H.</given-names>
</name>
<name>
<surname>Uliel</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2008</year>). <article-title>Elucidating the role of C/D snoRNA in rRNA processing and modification in Trypanosoma brucei</article-title>. <source>Eukaryot. Cell</source> <volume>7</volume> (<issue>1</issue>), <fpage>86</fpage>&#x2013;<lpage>101</lpage>. <pub-id pub-id-type="doi">10.1128/EC.00215-07</pub-id>
</citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Benmerzouga</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Concepci&#xf3;n&#x2010;Acevedo</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>H. S.</given-names>
</name>
<name>
<surname>Vandoros</surname>
<given-names>A. V.</given-names>
</name>
<name>
<surname>Cross</surname>
<given-names>G. A.</given-names>
</name>
<name>
<surname>Klingbeil</surname>
<given-names>M. M.</given-names>
</name>
<etal/>
</person-group> (<year>2013</year>). <article-title>T rypanosoma brucei Orc 1 is essential for nuclear DNA replication and affects both VSG silencing and VSG switching</article-title>. <source>Mol. Microbiol.</source> <volume>87</volume> (<issue>1</issue>), <fpage>196</fpage>&#x2013;<lpage>210</lpage>. <pub-id pub-id-type="doi">10.1111/mmi.12093</pub-id>
</citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Berman</surname>
<given-names>A. J.</given-names>
</name>
<name>
<surname>Gooding</surname>
<given-names>A. R.</given-names>
</name>
<name>
<surname>Cech</surname>
<given-names>T. R.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Tetrahymena telomerase protein p65 induces conformational changes throughout telomerase RNA (TER) and rescues telomerase reverse transcriptase and TER assembly mutants</article-title>. <source>J. Mol. Cell. Biol.</source> <volume>30</volume> (<issue>20</issue>), <fpage>4965</fpage>&#x2013;<lpage>4976</lpage>. <pub-id pub-id-type="doi">10.1128/MCB.00827-10</pub-id>
</citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Caruso Bavisotto</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Alberti</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Vitale</surname>
<given-names>A. M.</given-names>
</name>
<name>
<surname>Paladino</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Campanella</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Rappa</surname>
<given-names>F.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Hsp60 post-translational modifications: Functional and pathological consequences</article-title>. <source>Front. Mol. Biosci.</source> <volume>7</volume>, <fpage>95</fpage>. <pub-id pub-id-type="doi">10.3389/fmolb.2020.00095</pub-id>
</citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>J. L.</given-names>
</name>
<name>
<surname>Blasco</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Greider</surname>
<given-names>C. W.</given-names>
</name>
</person-group> (<year>2000</year>). <article-title>Secondary structure of vertebrate telomerase RNA</article-title>. <source>Cell</source> <volume>100</volume> (<issue>5</issue>), <fpage>503</fpage>&#x2013;<lpage>514</lpage>. <pub-id pub-id-type="doi">10.1016/s0092-8674(00)80687-x</pub-id>
</citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Roake</surname>
<given-names>C. M.</given-names>
</name>
<name>
<surname>Freund</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Batista</surname>
<given-names>P. J.</given-names>
</name>
<name>
<surname>Tian</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Yin</surname>
<given-names>Y. A.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>An activity switch in human telomerase based on RNA conformation and shaped by TCAB1</article-title>. <source>Cell</source> <volume>174</volume> (<issue>1</issue>), <fpage>218</fpage>&#x2013;<lpage>230</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2018.04.039</pub-id>
</citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Collins</surname>
<given-names>K.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>The biogenesis and regulation of telomerase holoenzymes</article-title>. <source>Nat. Rev. Mol. Cell Biol.</source> <volume>7</volume> (<issue>7</issue>), <fpage>484</fpage>&#x2013;<lpage>494</lpage>. <pub-id pub-id-type="doi">10.1038/nrm1961</pub-id>
</citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cotobal</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Rodr&#xed;guez-L&#xf3;pez</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Duncan</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Hasan</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Yamashita</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Yamamoto</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>Role of Ccr4-Not complex in heterochromatin formation at meiotic genes and subtelomeres in fission yeast</article-title>. <source>Epigenetics Chromatin</source> <volume>8</volume> (<issue>1</issue>), <fpage>28</fpage>&#x2013;<lpage>16</lpage>. <pub-id pub-id-type="doi">10.1186/s13072-015-0018-4</pub-id>
</citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>De Lange</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Borst</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>1982</year>). <article-title>Genomic environment of the expression-linked extra copies of genes for surface antigens of Trypanosoma brucei resembles the end of a chromosome</article-title>. <source>Nature</source> <volume>299</volume> (<issue>5882</issue>), <fpage>451</fpage>&#x2013;<lpage>453</lpage>. <pub-id pub-id-type="doi">10.1038/299451a0</pub-id>
</citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dey</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Chakrabarti</surname>
<given-names>K.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Current perspectives of telomerase structure and function in eukaryotes with emerging views on telomerase in human parasites</article-title>. <source>Int. J. Mol. Sci.</source> <volume>19</volume> (<issue>2</issue>), <fpage>333</fpage>. <pub-id pub-id-type="doi">10.3390/ijms19020333</pub-id>
</citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dey</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Monroy-Eklund</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Klotz</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Saha</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Davis</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>B.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>
<italic>In vivo</italic> architecture of the telomerase RNA catalytic core in Trypanosoma brucei</article-title>. <source>Nucleic Acids Res.</source> <volume>49</volume> (<issue>21</issue>), <fpage>12445</fpage>&#x2013;<lpage>12466</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkab1042</pub-id>
</citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dreesen</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Cross</surname>
<given-names>G. A.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Telomerase-independent stabilization of short telomeres in Trypanosoma brucei</article-title>. <source>Mol. Cell Biol.</source> <volume>26</volume> (<issue>13</issue>), <fpage>4911</fpage>&#x2013;<lpage>4919</lpage>. <pub-id pub-id-type="doi">10.1128/MCB.00212-06</pub-id>
</citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dreesen</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Cross</surname>
<given-names>G. A.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Telomere structure and shortening in telomerase-deficient Trypanosoma brucei</article-title>. <source>Nucleic Acids Res.</source> <volume>33</volume> (<issue>14</issue>), <fpage>4536</fpage>&#x2013;<lpage>4543</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gki769</pub-id>
</citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Du</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Xi</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>YTHDF2 destabilizes m6A-containing RNA through direct recruitment of the CCR4&#x2013;NOT deadenylase complex</article-title>. <source>Nat. Commun.</source> <volume>7</volume> (<issue>1</issue>), <fpage>12626</fpage>&#x2013;<lpage>12637</lpage>. <pub-id pub-id-type="doi">10.1038/ncomms12626</pub-id>
</citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Egan</surname>
<given-names>E. D.</given-names>
</name>
<name>
<surname>Collins</surname>
<given-names>K.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>An enhanced H/ACA RNP assembly mechanism for human telomerase RNA</article-title>. <source>Mol. Cell Biol.</source> <volume>32</volume> (<issue>13</issue>), <fpage>2428</fpage>&#x2013;<lpage>2439</lpage>. <pub-id pub-id-type="doi">10.1128/MCB.00286-12</pub-id>
</citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ferguson</surname>
<given-names>J. L.</given-names>
</name>
<name>
<surname>Chao</surname>
<given-names>W. C. H.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Friedman</surname>
<given-names>K. L.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>The anaphase promoting complex contributes to the degradation of the <italic>S. cerevisiae</italic> telomerase recruitment subunit Est1p</article-title>. <source>PLoS One</source> <volume>8</volume> (<issue>1</issue>), <fpage>e55055</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0055055</pub-id>
</citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fu</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Collins</surname>
<given-names>K.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Purification of human telomerase complexes identifies factors involved in telomerase biogenesis and telomere length regulation</article-title>. <source>Mol. Cell</source> <volume>28</volume> (<issue>5</issue>), <fpage>773</fpage>&#x2013;<lpage>785</lpage>. <pub-id pub-id-type="doi">10.1016/j.molcel.2007.09.023</pub-id>
</citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Greider</surname>
<given-names>C. W.</given-names>
</name>
<name>
<surname>Blackburn</surname>
<given-names>E. H.</given-names>
</name>
</person-group> (<year>1989</year>). <article-title>A telomeric sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesis</article-title>. <source>Nature</source> <volume>337</volume> (<issue>6205</issue>), <fpage>331</fpage>&#x2013;<lpage>337</lpage>. <pub-id pub-id-type="doi">10.1038/337331a0</pub-id>
</citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gupta</surname>
<given-names>S. K.</given-names>
</name>
<name>
<surname>Kolet</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Doniger</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Biswas</surname>
<given-names>V. K.</given-names>
</name>
<name>
<surname>Unger</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Tzfati</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2013</year>). <article-title>The Trypanosoma brucei telomerase RNA (TER) homologue binds core proteins of the C/D snoRNA family</article-title>. <source>FEBS Lett.</source> <volume>587</volume> (<issue>9</issue>), <fpage>1399</fpage>&#x2013;<lpage>1404</lpage>. <pub-id pub-id-type="doi">10.1016/j.febslet.2013.03.017</pub-id>
</citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Han</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>B. S.</given-names>
</name>
<name>
<surname>Myers</surname>
<given-names>S. A.</given-names>
</name>
<name>
<surname>Carr</surname>
<given-names>S. A.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Ting</surname>
<given-names>A. Y.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>RNA&#x2013;protein interaction mapping via MS2-or Cas13-based APEX targeting</article-title>. <source>Proc. Natl. Acad. Sci. USA</source> <volume>117</volume> (<issue>36</issue>), <fpage>22068</fpage>&#x2013;<lpage>22079</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.2006617117</pub-id>
</citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>He</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Helmling</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Su&#x161;ac</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>R.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Structures of telomerase at several steps of telomere repeat synthesis</article-title>. <source>Nature</source> <volume>593</volume> (<issue>7859</issue>), <fpage>454</fpage>&#x2013;<lpage>459</lpage>. <pub-id pub-id-type="doi">10.1038/s41586-021-03529-9</pub-id>
</citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hertz-Fowler</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Figueiredo</surname>
<given-names>L. M.</given-names>
</name>
<name>
<surname>Quail</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Becker</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Jackson</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Bason</surname>
<given-names>N.</given-names>
</name>
<etal/>
</person-group> (<year>2008</year>). <article-title>Telomeric expression sites are highly conserved in Trypanosoma brucei</article-title>. <source>PLoS One</source> <volume>3</volume> (<issue>10</issue>), <fpage>e3527</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0003527</pub-id>
</citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Holm</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Rosenstr&#xf6;m</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Dali server: Conservation mapping in 3D</article-title>. <source>Nucleic Acids Res.</source> <volume>38</volume>, <fpage>W545</fpage>&#x2013;<lpage>W549</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkq366</pub-id>
</citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Holt</surname>
<given-names>S. E.</given-names>
</name>
<name>
<surname>Aisner</surname>
<given-names>D. L.</given-names>
</name>
<name>
<surname>Baur</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Tesmer</surname>
<given-names>V. M.</given-names>
</name>
<name>
<surname>Dy</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ouellette</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>1999</year>). <article-title>Functional requirement of p23 and Hsp90 in telomerase complexes</article-title>. <source>Genes Dev.</source> <volume>13</volume> (<issue>7</issue>), <fpage>817</fpage>&#x2013;<lpage>826</lpage>. <pub-id pub-id-type="doi">10.1101/gad.13.7.817</pub-id>
</citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hovel-Miner</surname>
<given-names>G. A.</given-names>
</name>
<name>
<surname>Boothroyd</surname>
<given-names>C. E.</given-names>
</name>
<name>
<surname>Mugnier</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Dreesen</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Cross</surname>
<given-names>G. A.</given-names>
</name>
<name>
<surname>Papavasiliou</surname>
<given-names>F. N.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Telomere length affects the frequency and mechanism of antigenic variation in Trypanosoma brucei</article-title>. <source>PLoS Pathog.</source> <volume>8</volume> (<issue>8</issue>), <fpage>e1002900</fpage>. <pub-id pub-id-type="doi">10.1371/journal.ppat.1002900</pub-id>
</citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Indran</surname>
<given-names>I. R.</given-names>
</name>
<name>
<surname>Hande</surname>
<given-names>M. P.</given-names>
</name>
<name>
<surname>Pervaiz</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>hTERT overexpression alleviates intracellular ROS production, improves mitochondrial function, and inhibits ROS-mediated apoptosis in cancer cells</article-title>. <source>Cancer Res.</source> <volume>71</volume> (<issue>1</issue>), <fpage>266</fpage>&#x2013;<lpage>276</lpage>. <pub-id pub-id-type="doi">10.1158/0008-5472.CAN-10-1588</pub-id>
</citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jehi</surname>
<given-names>S. E.</given-names>
</name>
<name>
<surname>Nanavaty</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>B.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Trypanosoma brucei TIF2 and TRF suppress VSG switching using overlapping and independent mechanisms</article-title>. <source>PLoS One</source> <volume>11</volume> (<issue>6</issue>), <fpage>e0156746</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0156746</pub-id>
</citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jehi</surname>
<given-names>S. E.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>B.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Trypanosoma brucei TIF2 suppresses VSG switching by maintaining subtelomere integrity</article-title>. <source>Cell Res.</source> <volume>24</volume> (<issue>7</issue>), <fpage>870</fpage>&#x2013;<lpage>885</lpage>. <pub-id pub-id-type="doi">10.1038/cr.2014.60</pub-id>
</citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jumper</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Evans</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Pritzel</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Green</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Figurnov</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ronneberger</surname>
<given-names>O.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Highly accurate protein structure prediction with AlphaFold</article-title>. <source>Nature</source> <volume>596</volume> (<issue>7873</issue>), <fpage>583</fpage>&#x2013;<lpage>589</lpage>. <pub-id pub-id-type="doi">10.1038/s41586-021-03819-2</pub-id>
</citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jung</surname>
<given-names>H.-Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Jun</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>J.-I.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Dyrk2-associated EDD-DDB1-VprBP E3 ligase inhibits telomerase by TERT degradation</article-title>. <source>J. Biol. Chem.</source> <volume>288</volume> (<issue>10</issue>), <fpage>7252</fpage>&#x2013;<lpage>7262</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M112.416792</pub-id>
</citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Klebanov-Akopyan</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Mishra</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Glousker</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Tzfati</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Shlomai</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Trypanosoma brucei UMSBP2 is a single-stranded telomeric DNA binding protein essential for chromosome end protection</article-title>. <source>Nucleic Acids Res.</source> <volume>46</volume> (<issue>15</issue>), <fpage>7757</fpage>&#x2013;<lpage>7771</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gky597</pub-id>
</citation>
</ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Krissinel</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Henrick</surname>
<given-names>K.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>Secondary-structure matching (SSM), a new tool for fast protein structure alignment in three dimensions</article-title>. <source>Acta Crystallogr. D. Biol. Crystallogr.</source> <volume>60</volume> (<issue>12</issue>), <fpage>2256</fpage>&#x2013;<lpage>2268</lpage>. <pub-id pub-id-type="doi">10.1107/S0907444904026460</pub-id>
</citation>
</ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lin</surname>
<given-names>K.-W.</given-names>
</name>
<name>
<surname>McDonald</surname>
<given-names>K. R.</given-names>
</name>
<name>
<surname>Guise</surname>
<given-names>A. J.</given-names>
</name>
<name>
<surname>Chan</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Cristea</surname>
<given-names>I. M.</given-names>
</name>
<name>
<surname>Zakian</surname>
<given-names>V. A.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Proteomics of yeast telomerase identified Cdc48-Npl4-Ufd1 and Ufd4 as regulators of Est1 and telomere length</article-title>. <source>Nat. Commun.</source> <volume>6</volume> (<issue>1</issue>), <fpage>8290</fpage>&#x2013;<lpage>8304</lpage>. <pub-id pub-id-type="doi">10.1038/ncomms9290</pub-id>
</citation>
</ref>
<ref id="B41">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mitchell</surname>
<given-names>J. R.</given-names>
</name>
<name>
<surname>Collins</surname>
<given-names>K.</given-names>
</name>
</person-group> (<year>2000</year>). <article-title>Human telomerase activation requires two independent interactions between telomerase RNA and telomerase reverse transcriptase</article-title>. <source>Mol. Cell</source> <volume>6</volume> (<issue>2</issue>), <fpage>361</fpage>&#x2013;<lpage>371</lpage>. <pub-id pub-id-type="doi">10.1016/s1097-2765(00)00036-8</pub-id>
</citation>
</ref>
<ref id="B42">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mochizuki</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Kulkarni</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Bessler</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Mason</surname>
<given-names>P. J.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>Mouse dyskerin mutations affect accumulation of telomerase RNA and small nucleolar RNA, telomerase activity, and ribosomal RNA processing</article-title>. <source>Proc. Natl. Acad. Sci. USA</source> <volume>101</volume> (<issue>29</issue>), <fpage>10756</fpage>&#x2013;<lpage>10761</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0402560101</pub-id>
</citation>
</ref>
<ref id="B43">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moon</surname>
<given-names>D. H.</given-names>
</name>
<name>
<surname>Segal</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Boyraz</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Guinan</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Hofmann</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Cahan</surname>
<given-names>P.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>Poly (A)-specific ribonuclease (PARN) mediates 3&#x2032;-end maturation of the telomerase RNA component</article-title>. <source>Nat. Genet.</source> <volume>47</volume> (<issue>12</issue>), <fpage>1482</fpage>&#x2013;<lpage>1488</lpage>. <pub-id pub-id-type="doi">10.1038/ng.3423</pub-id>
</citation>
</ref>
<ref id="B44">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nanavaty</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Sandhu</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Jehi</surname>
<given-names>S. E.</given-names>
</name>
<name>
<surname>Pandya</surname>
<given-names>U. M.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>B.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Trypanosoma brucei RAP1 maintains telomere and subtelomere integrity by suppressing TERRA and telomeric RNA: DNA hybrids</article-title>. <source>Nucleic Acids Res.</source> <volume>45</volume> (<issue>10</issue>), <fpage>5785</fpage>&#x2013;<lpage>5796</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkx184</pub-id>
</citation>
</ref>
<ref id="B45">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nittis</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Guittat</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>LeDuc</surname>
<given-names>R. D.</given-names>
</name>
<name>
<surname>Dao</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Duxin</surname>
<given-names>J. P.</given-names>
</name>
<name>
<surname>Rohrs</surname>
<given-names>H.</given-names>
</name>
<etal/>
</person-group> (<year>2010</year>). <article-title>Revealing novel telomere proteins using <italic>in vivo</italic> cross-linking, tandem affinity purification, and label-free quantitative LC-FTICR-MS</article-title>. <source>Mol. Cell Proteomics</source> <volume>9</volume> (<issue>6</issue>), <fpage>1144</fpage>&#x2013;<lpage>1156</lpage>. <pub-id pub-id-type="doi">10.1074/mcp.M900490-MCP200</pub-id>
</citation>
</ref>
<ref id="B46">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Peters</surname>
<given-names>J.-M.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>The anaphase promoting complex/cyclosome: A machine designed to destroy</article-title>. <source>Nat. Rev. Mol. Cell Biol.</source> <volume>7</volume> (<issue>9</issue>), <fpage>644</fpage>&#x2013;<lpage>656</lpage>. <pub-id pub-id-type="doi">10.1038/nrm1988</pub-id>
</citation>
</ref>
<ref id="B48">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Podlevsky</surname>
<given-names>J. D.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>J. J.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>The functional requirement of two structural domains within telomerase RNA emerged early in eukaryotes</article-title>. <source>Nucleic Acids Res.</source> <volume>44</volume> (<issue>20</issue>), <fpage>9891</fpage>&#x2013;<lpage>9901</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkw605</pub-id>
</citation>
</ref>
<ref id="B49">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rabbani</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Tonini</surname>
<given-names>M. L.</given-names>
</name>
<name>
<surname>Afrin</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>B.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>POLIE suppresses telomerase-mediated telomere G-strand extension and helps ensure proper telomere C-strand synthesis in trypanosomes</article-title>. <source>Nucleic Acids Res.</source> <volume>50</volume> (<issue>4</issue>), <fpage>2036</fpage>&#x2013;<lpage>2050</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkac023</pub-id>
</citation>
</ref>
<ref id="B50">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roake</surname>
<given-names>C. M.</given-names>
</name>
<name>
<surname>Artandi</surname>
<given-names>S. E.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Regulation of human telomerase in homeostasis and disease</article-title>. <source>Nat. Rev. Mol. Cell Biol.</source> <volume>21</volume> (<issue>7</issue>), <fpage>384</fpage>&#x2013;<lpage>397</lpage>. <pub-id pub-id-type="doi">10.1038/s41580-020-0234-z</pub-id>
</citation>
</ref>
<ref id="B51">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Saha</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Nanavaty</surname>
<given-names>V. P.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>B.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Telomere and subtelomere R-loops and antigenic variation in trypanosomes</article-title>. <source>J. Mol. Biol.</source> <volume>432</volume> (<issue>15</issue>), <fpage>4167</fpage>&#x2013;<lpage>4185</lpage>. <pub-id pub-id-type="doi">10.1016/j.jmb.2019.10.025</pub-id>
</citation>
</ref>
<ref id="B52">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sandhu</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Sanford</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Basu</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Pandya</surname>
<given-names>U. M.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>B.</given-names>
</name>
<etal/>
</person-group> (<year>2013</year>). <article-title>A trans-spliced telomerase RNA dictates telomere synthesis in Trypanosoma brucei</article-title>. <source>Cell Res.</source> <volume>23</volume> (<issue>4</issue>), <fpage>537</fpage>&#x2013;<lpage>551</lpage>. <pub-id pub-id-type="doi">10.1038/cr.2013.35</pub-id>
</citation>
</ref>
<ref id="B53">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Santos</surname>
<given-names>J. H.</given-names>
</name>
<name>
<surname>Meyer</surname>
<given-names>J. N.</given-names>
</name>
<name>
<surname>Skorvaga</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Annab</surname>
<given-names>L. A.</given-names>
</name>
<name>
<surname>Van Houten</surname>
<given-names>B.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>Mitochondrial hTERT exacerbates free&#x2010;radical&#x2010;mediated mtDNA damage</article-title>. <source>Aging Cell</source> <volume>3</volume> (<issue>6</issue>), <fpage>399</fpage>&#x2013;<lpage>411</lpage>. <pub-id pub-id-type="doi">10.1111/j.1474-9728.2004.00124.x</pub-id>
</citation>
</ref>
<ref id="B54">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schuberth</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Richly</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Rumpf</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Buchberger</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>Shp1 and Ubx2 are adaptors of Cdc48 involved in ubiquitin&#x2010;dependent protein degradation</article-title>. <source>EMBO Rep.</source> <volume>5</volume> (<issue>8</issue>), <fpage>818</fpage>&#x2013;<lpage>824</lpage>. <pub-id pub-id-type="doi">10.1038/sj.embor.7400203</pub-id>
</citation>
</ref>
<ref id="B55">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sealey</surname>
<given-names>D. C.</given-names>
</name>
<name>
<surname>Kostic</surname>
<given-names>A. D.</given-names>
</name>
<name>
<surname>LeBel</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Pryde</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Harrington</surname>
<given-names>L.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>The TPR-containing domain within Est1 homologs exhibits species-specific roles in telomerase interaction and telomere length homeostasis</article-title>. <source>BMC Mol. Biol.</source> <volume>12</volume> (<issue>1</issue>), <fpage>45</fpage>&#x2013;<lpage>15</lpage>. <pub-id pub-id-type="doi">10.1186/1471-2199-12-45</pub-id>
</citation>
</ref>
<ref id="B56">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sharma</surname>
<given-names>N. K.</given-names>
</name>
<name>
<surname>Reyes</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Green</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Caron</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>Bonini</surname>
<given-names>M. G.</given-names>
</name>
<name>
<surname>Gordon</surname>
<given-names>D. M.</given-names>
</name>
<etal/>
</person-group> (<year>2012</year>). <article-title>Human telomerase acts as a hTR-independent reverse transcriptase in mitochondria</article-title>. <source>Nucleic Acids Res.</source> <volume>40</volume> (<issue>2</issue>), <fpage>712</fpage>&#x2013;<lpage>725</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkr758</pub-id>
</citation>
</ref>
<ref id="B57">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shay</surname>
<given-names>J. W.</given-names>
</name>
<name>
<surname>Wright</surname>
<given-names>W. E.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Telomeres and telomerase: Three decades of progress</article-title>. <source>Nat. Rev. Genet.</source> <volume>20</volume> (<issue>5</issue>), <fpage>299</fpage>&#x2013;<lpage>309</lpage>. <pub-id pub-id-type="doi">10.1038/s41576-019-0099-1</pub-id>
</citation>
</ref>
<ref id="B58">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Singh</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Koo</surname>
<given-names>B.-K.</given-names>
</name>
<name>
<surname>Patel</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Cascio</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Collins</surname>
<given-names>K.</given-names>
</name>
<etal/>
</person-group> (<year>2012</year>). <article-title>Structural basis for telomerase RNA recognition and RNP assembly by the holoenzyme La family protein p65</article-title>. <source>Mol. Cell</source> <volume>47</volume> (<issue>1</issue>), <fpage>16</fpage>&#x2013;<lpage>26</lpage>. <pub-id pub-id-type="doi">10.1016/j.molcel.2012.05.018</pub-id>
</citation>
</ref>
<ref id="B59">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Kannan</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Blanchette</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Baumann</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Telomerase RNA biogenesis involves sequential binding by Sm and Lsm complexes</article-title>. <source>Nature</source> <volume>484</volume> (<issue>7393</issue>), <fpage>260</fpage>&#x2013;<lpage>264</lpage>. <pub-id pub-id-type="doi">10.1038/nature10924</pub-id>
</citation>
</ref>
<ref id="B60">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Te Raa</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Derks</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Navrkalov&#xe1;</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Skowronska</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Moerland</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Van Laar</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>The impact of SF3B1 mutations in CLL on the DNA-damage response</article-title>. <source>Leukemia</source> <volume>29</volume> (<issue>5</issue>), <fpage>1133</fpage>&#x2013;<lpage>1142</lpage>. <pub-id pub-id-type="doi">10.1038/leu.2014.318</pub-id>
</citation>
</ref>
<ref id="B61">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tian</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Weizmann</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Real-time detection of telomerase activity using the exponential isothermal amplification of telomere repeat assay</article-title>. <source>J. Am. Chem. Soc.</source> <volume>135</volume> (<issue>5</issue>), <fpage>1661</fpage>&#x2013;<lpage>1664</lpage>. <pub-id pub-id-type="doi">10.1021/ja309198j</pub-id>
</citation>
</ref>
<ref id="B62">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tyanova</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Temu</surname>
<given-names>Tikira.</given-names>
</name>
<name>
<surname>Cox</surname>
<given-names>Juergen.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>The MaxQuant computational platform for mass spectrometry-based shotgun proteomics</article-title>. <source>Nat. Protoc.</source> <volume>11</volume>, <fpage>2301</fpage>&#x2013;<lpage>2319</lpage>. <pub-id pub-id-type="doi">10.1038/nprot.2016.136</pub-id>
</citation>
</ref>
<ref id="B63">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Upton</surname>
<given-names>H. E.</given-names>
</name>
<name>
<surname>Chan</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Feigon</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Collins</surname>
<given-names>K. J. J. o. B. C.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Shared subunits of Tetrahymena telomerase holoenzyme and replication protein A have different functions in different cellular complexes</article-title>. <source>J. Biol. Chem.</source> <volume>292</volume> (<issue>1</issue>), <fpage>217</fpage>&#x2013;<lpage>228</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M116.763664</pub-id>
</citation>
</ref>
<ref id="B64">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vasconcelos</surname>
<given-names>E. J.</given-names>
</name>
<name>
<surname>Nunes</surname>
<given-names>V. S.</given-names>
</name>
<name>
<surname>da Silva</surname>
<given-names>M. S.</given-names>
</name>
<name>
<surname>Segatto</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Myler</surname>
<given-names>P. J.</given-names>
</name>
<name>
<surname>Cano</surname>
<given-names>M. I. N.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>The putative Leishmania telomerase RNA (Leish TER) undergoes trans-splicing and contains a conserved template sequence</article-title>. <source>PLoS One</source> <volume>9</volume> (<issue>11</issue>), <fpage>e112061</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0112061</pub-id>
</citation>
</ref>
<ref id="B65">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Venteicher</surname>
<given-names>A. S.</given-names>
</name>
<name>
<surname>Meng</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Mason</surname>
<given-names>P. J.</given-names>
</name>
<name>
<surname>Veenstra</surname>
<given-names>T. D.</given-names>
</name>
<name>
<surname>Artandi</surname>
<given-names>S. E.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Identification of ATPases pontin and reptin as telomerase components essential for holoenzyme assembly</article-title>. <source>Cell</source> <volume>132</volume> (<issue>6</issue>), <fpage>945</fpage>&#x2013;<lpage>957</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2008.01.019</pub-id>
</citation>
</ref>
<ref id="B66">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Brooks</surname>
<given-names>A. N.</given-names>
</name>
<name>
<surname>Fan</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wan</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Gambe</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>Transcriptomic characterization of SF3B1 mutation reveals its pleiotropic effects in chronic lymphocytic leukemia</article-title>. <source>Cancer Cell</source> <volume>30</volume> (<issue>5</issue>), <fpage>750</fpage>&#x2013;<lpage>763</lpage>. <pub-id pub-id-type="doi">10.1016/j.ccell.2016.10.005</pub-id>
</citation>
</ref>
<ref id="B67">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Susac</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Feigon</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Structural biology of telomerase</article-title>. <source>Cold Spring Harb. Perspect. Biol.</source> <volume>11</volume> (<issue>12</issue>), <fpage>a032383</fpage>. <pub-id pub-id-type="doi">10.1101/cshperspect.a032383</pub-id>
</citation>
</ref>
<ref id="B68">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wirtz</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Leal</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ochatt</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Cross</surname>
<given-names>G. A.</given-names>
</name>
</person-group> (<year>1999</year>). <article-title>A tightly regulated inducible expression system for conditional gene knock-outs and dominant-negative genetics in Trypanosoma brucei</article-title>. <source>Mol. Biochem Parasitol.</source> <volume>99</volume> (<issue>1</issue>), <fpage>89</fpage>&#x2013;<lpage>101</lpage>. <pub-id pub-id-type="doi">10.1016/s0166-6851(99)00002-x</pub-id>
</citation>
</ref>
<ref id="B69">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Witkin</surname>
<given-names>K. L.</given-names>
</name>
<name>
<surname>Collins</surname>
<given-names>K.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>Holoenzyme proteins required for the physiological assembly and activity of telomerase</article-title>. <source>Genes Dev.</source> <volume>18</volume> (<issue>10</issue>), <fpage>1107</fpage>&#x2013;<lpage>1118</lpage>. <pub-id pub-id-type="doi">10.1101/gad.1201704</pub-id>
</citation>
</ref>
<ref id="B70">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Figueiredo</surname>
<given-names>L. M.</given-names>
</name>
<name>
<surname>Espinal</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Okubo</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>B.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>RAP1 is essential for silencing telomeric variant surface glycoprotein genes in Trypanosoma brucei</article-title>. <source>Cell</source> <volume>137</volume> (<issue>1</issue>), <fpage>99</fpage>&#x2013;<lpage>109</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2009.01.037</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>